Materials and methods for the treatment of latent viral infection
The subject invention pertains to materials and methods for the treatment of latent viral infections.
1. A method of treating a latent viral infection comprising the administration of a fusion protein comprising a TAL binding domain that binds a target gene of a latent virus and an effector domain to a subject having a latent viral infection, wherein (a) the target gene is selected from ICP27, ICP0, ICP4, UL5, UL7, UL30, LAT and/or UL25, (b) the effector domain is an endonuclease, and (c) the fusion protein modulates the target gene of the latent virus, wherein the viral infection is caused by an HSV-1 or HSV-2 virus.
2. A method of treating a latent viral infection comprising the administration of a vector encoding the fusion protein according to claim 1 to a subject having a latent viral infection.
3. The method of claim 1 , wherein the target gene is ICP4 and the effector domain is Mme1.